NR 546 PSYCHOPHARM MIDTERM EXAM 2024 ACTUAL EXAM COMPLETE 200 QUESTIONS WITH DETAILED VERIFIED ANSWERS (100% CORRECT) /ALREADY GRADED A+

NR 546 PSYCHOPHARM MIDTERM EXAM 2024 ACTUAL EXAM
COMPLETE 200 QUESTIONS WITH DETAILED VERIFIED ANSWERS
(100% CORRECT) /ALREADY GRADED A+
1. How does the orbitofrontal cortex (OFC) affect the amygdala?
YY YY YY YY YY YY YY YY




..ANSWER>> inhibits and activates the amygdala
Y YY YY YY YY




2. Wernicke's area is associated with which of the following?
YY YY YY YY YY YY YY YY




Y ..ANSWER>> speech compre- hension YY YY YY




3. The limbic system is associated with which of the following
YY YY YY YY YY YY YY YY YY




..ANSWER>> emotion and learning YY YY YY




4. Which brain structure is most associated with long term memory?
YY YY YY YY YY YY YY YY YY




Y ..ANSWER>>hip- pocampus YY




5. When prescribing psychotropic medications, the PMHNP knows that these
YY YY YY YY YY YY YY YY medications work
YY YY




YY within which specific areas?
YY YY YY




Y ..ANSWER>> mood YY




6. Which YYof the following are involved in regulating neurotransmission via ex- citation-secretion
YY YY YY YY YY YY YY YY YY YY




YY coupling?
Y ..ANSWER>> voltage-sensitive sodium channels and voltage-sen- sitive calcium channels
Y YY YY YY YY YY YY YY




7. What system influences the length of time for a drug to achieve efficacy?
YY YY YY YY YY YY YY YY YY YY YY YY




Y ..ANSWER>>signal transduction cascades YY YY




8. One of the signal transduction cascades, pass the message from a first
YY YY YY YY YY YY YY YY YY YY YY YY receptor to a second
YY YY YY




messenger
YY




..ANSWER>> G protein linked systems YY YY YY YY




9. Human central nervous system communication at synapses is which of the
YY YY YY YY YY YY YY YY YY YY YY following?
Y ..ANSWER>> chemical Y




10. Which of the following is an excitatory neurotransmitter?
YY YY YY YY YY YY YY




1|Page
Y Y

, ..ANSWER>> glutamate
Y Y




11. Which statement correctly pairs the pharmacodynamic effect with its defi-
YY YY nition? YY YY YY YY YY YY YY YY




Y ..ANSWER>> antagonist effect - drug binds to receptor, but does not activate a response
Y YY YY YY YY YY YY YY YY YY YY YY YY




12. A major current hypothesis for the cause of schizophrenia proposes that
YY YY YY YY YY YY YY YY YY YY YY N-methyl-d-aspartate
YY (NMDA) receptors may be which of the following? Correct!
YY YY YY YY YY YY YY YY




Y ..ANSWER>> hypofunctional Y




13. Which medication is YY least associated with weight gain? YY YY YY YY YY YY




Y ..ANSWER>> aripiprazole Y




14. Which dopamine pathway is associated with positive symptoms of schiz-
YY YY YY YY YY YY YY YY YY YY ophrenia?
Y ..ANSWER>> mesolimbic pathway YY YY




15. Which pathway is associated with negative symptoms?
YY YY YY YY YY YY




Y ..ANSWER>>The mesocortical pathway YY YY




16. Is part of the extrapyramidal nervous system and associated with ex-
YY YY YY YY YY YY YY YY YY YY YY trapyramidal
YY symptoms (EPS) YY




Y ..ANSWER>> nigrostriatal pathway YY YY




17. This pathway is associated with hyperprolactinemia
YY YY YY YY YY




..ANSWER>>The tuberoinfundibu- lar pathway YY YY YY




18. A 34-year old male recently began experiencing breast secretions while receiving risperidone
YY YY YY YY YY YY YY YY YY YY YY




YY .Which dopamine pathway is associated with this side effect?
Y YY YY YY YY YY YY YY YY




Y ..ANSWER>> tuberoinfundibular pathway YY YY




19. A 44-year-old woman is initiated on an atypical antipsychotic for the treatment of
YY YY YY YY YY YY YY YY YY YY YY YY




YY schizophrenia. Regarding affinity, atypical antipsychotics demon-
Y YY Y YY YY




2|Page Y Y